The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
A double‐blind, randomized, placebo‐controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca
Abstract
Objective: To evaluate the safety and efficacy of 2 dosages of cevimeline for the treatment of xerostomia and keratoconjunctivitis sicca in patients with Sjögren's syndrome. Methods: A 12‐week double‐blind, randomized, placebo‐controlled study was performed. Patients were randomly assigned to receive either placebo, 15 mg of cevimeline 3 times daily, or 30 mg of cevimeline 3 times daily. Patients were evaluated at baseline and throughout the study for their global assessment of dryness (mouth, eyes, overall) as well as their subjective assessment of the specific symptoms of dry mouth and dry eyes. Total saliva and tear flow also were measured. Results: Patients taking 30 mg of cevimeline 3 times daily had statistically significant improvements in their subjective global assessment of dry eyes (P = 0.0453), dry mouth (P = 0.0004), and increased salivary flow (P = 0.007). Patients receiving the 30‐mg dosage also showed greater objective improvement (increased salivary and lacrimal flow rates, as measured by Schirmer's test) than did patients receiving placebo. Frequently reported adverse events included headache, increased sweating, abdominal pain, and nausea. Conclusion: Treatment with cevimeline at a dosage of 30 mg 3 times daily resulted in substantive improvement by increasing the rate of saliva and tear flow in patients with Sjögren's syndrome, as well as improving subjective symptoms of dry mouth, dry eyes, and overall dryness. The 15‐mg dosage relieved some symptoms, and both dosages were well tolerated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harrison's Principles of Internal Medicine
Massarelli, J. J. (1984) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1984.03340300091039 · Cited by 1,132
Akin, R. K., Kreller, A. J., & Walters, P. J. (1975) · Plastic and Reconstructive Surgery · doi:10.1097/00006534-197510000-00031 · Cited by 240
SALIVARY AND ORAL COMPONENTS OF SJÖGREN’S SYNDROME
Daniels, T. E., & Fox, P. C. (1992) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(21)00317-3 · Cited by 212
Evidence that M3 muscarinic receptors in rat parotid gland couple to two second messenger systems
Dai, Y. S., Ambudkar, I. S., Horn, V., Yeh, C., Kousvelari, E. E., Wall, S. J., Li, M., Yasuda, R. P., Wolfe, B. B., & Baum, B. J. (1991) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1991.261.6.c1063 · Cited by 114
Sjögren's syndrome comes of age
Anaya, J., & Talal, N. (1999) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(99)80001-8 · Cited by 67
Iwabuchi, Y., & Masuhara, T. (1994) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(94)90021-3 · Cited by 58
Long-lasting salivation induced by a novel muscarinic receptor agonist SNI-2011 in rats and dogs
Masunaga, H., Ogawa, H., Uematsu, Y., Tomizuka, T., Yasuda, H., & Takeshita, Y. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01338-1 · Cited by 41
Characterization of muscarinic acetylcholine receptors in human labial salivary glands
Mei, L., Roeske, W. R., Izutsu, K. T., et al. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90032-2 · Cited by 30
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
TFOS DEWS II Management and Therapy Report
Jones, L., Downie, L. E., Korb, D., Benitez-del-Castillo, J. M., Dana, R., Deng, S. X., Dong, P. N., Geerling, G., Hida, R. Y., Liu, Y., et al. (2017) · The Ocular Surface · doi:10.1016/j.jtos.2017.05.006 · Cited by 1,422
Clinical Manifestations and Early Diagnosis of Sjögren Syndrome
Kassan, S. S., & Moutsopoulos, H. M. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.12.1275 · Cited by 698
Seror, R., Ravaud, P., Mariette, X., Bootsma, H., Theander, E., Hansen, A., Ramos-Casals, M., Dörner, T., Bombardieri, S., Hachulla, E., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.143743 · Cited by 576
(2007) · The Ocular Surface · doi:10.1016/s1542-0124(12)70085-x · Cited by 565
Metadata
- Authors
- Petrone, D., Condemi, J. J., Fife, R., Gluck, O., Cohen, S., & Dalgin, P.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2002-03
- Volume
- 46
- Issue
- 3
- Pages
- 748-754
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2072785268
- Cited by
- 282
- References
- 8
- FWCI
- 6.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.